Meridian Bioscience, Inc., a leading player in the life sciences industry, is headquartered in the United States. Founded in 1976, the company has established itself as a key provider of diagnostic products and life science reagents, primarily focusing on infectious disease testing and molecular diagnostics. With a strong presence in North America and Europe, Meridian Bioscience is renowned for its innovative solutions, including its proprietary immunoassay and molecular technologies. The company’s commitment to quality and accuracy has positioned it as a trusted partner in the healthcare sector. Notable achievements include significant advancements in rapid testing methodologies, which have enhanced patient care and diagnostic efficiency. Meridian Bioscience continues to drive progress in the industry, making it a pivotal entity in the realm of bioscience.
How does Meridian Bioscience, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Meridian Bioscience, Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Meridian Bioscience, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As such, there are no reported figures for their Scope 1, 2, or 3 emissions. The company has not outlined any formal climate commitments or initiatives aimed at reducing carbon emissions. In the absence of specific data, it is essential to note that many companies in the biotechnology sector are increasingly focusing on sustainability and climate action, often setting ambitious targets to mitigate their environmental impact. However, without concrete information from Meridian Bioscience, Inc., it is challenging to assess their current stance on climate commitments or emissions reduction strategies.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Meridian Bioscience, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.